Journey Medical Corporation DERM Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$11.43M— | —— | -$3.85M+87.0% | -$29.63M+32.7% | ||
| $6.29M+3.1% | $6.1M+134% | $2.61M-41.1% | $4.43M+79.4% | ||
| —— | —— | —— | $284K+492% | ||
| —— | —— | —— | —— | ||
| -$5.16M-222% | $4.23M+207% | -$3.95M-127% | -$1.74M— | ||
| -$7.2M— | —— | -$18.42M-228% | $14.34M— | ||
| —— | —— | $962K— | —— | ||
| $164K— | —— | $279K-68.0% | $871K+12.5% | ||
| —— | $7K-61.1% | $18K— | —— | ||
| $4.26M+24.4% | $3.42M-9.1% | $3.77M-11.2% | $4.24M+71.5% | ||
| $88K-3.3% | $91K+3.4% | $88K0.0% | $88K+2.3% | ||
| -$82K+14.6% | -$96K-15.7% | -$83K+12.6% | -$95K-13.1% | ||
| $466K+51.8% | $307K-13.8% | $356K+465% | $63K— | ||
| -$12.44M— | —— | —— | -$13.53M-521% | ||
| —— | —— | —— | —— | ||
| $16.36M+108% | $7.88M— | —— | —— | ||
| $16.23M-6.1% | $17.29M— | —— | $16.46M-69.0% | ||
| —— | -$7.13M— | —— | -$17.08M— | ||
| $3.24M+61.0% | $2.01M+78.4% | $1.13M+13.5% | $993K— | ||
| $466K+51.8% | $307K-13.8% | $356K+465% | $63K— | ||
| $4.26M+24.4% | $3.42M-9.1% | $3.77M-11.2% | $4.24M+71.5% | ||
| -$73K-122% | $333K+253% | -$218K— | —— | ||
| -$6K-102% | $382K— | —— | $160K— | ||
| -$82K+14.6% | -$96K-15.7% | -$83K+12.6% | -$95K-13.1% | ||
| $164K— | —— | $279K-68.0% | $871K+12.5% | ||
| $88K-3.3% | $91K+3.4% | $88K0.0% | $88K+2.3% | ||
| —— | —— | —— | $284K+492% | ||
| —— | —— | —— | —— | ||
| —— | —— | $1M-80.0% | $5M-5.7% | ||
| -$82K+14.6% | -$96K-15.7% | -$83K+12.6% | -$95K-13.1% | ||
| —— | $188K0.0% | $188K0.0% | $188K— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Journey Medical Corporation generate?
- Journey Medical Corporation (DERM) generated -$6.7M in operating cash flow over the trailing twelve months.
- Where does Journey Medical Corporation's cash flow data come from?
- Every line is extracted from Journey Medical Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
